Back to Journals » International Journal of Nanomedicine » Volume 14

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

Total article views   Abstract views HTML views PDF downloads Totals
4,789 Dovepress* 3,052 1,479+ 1,036 4,531
PubMed Central* 0 258 49 258
Totals 3,052 1,737 1,085 4,789
*Since 6 September 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar